Rakovina Therapeutics (TSXV:RKV) Ending Cash Position : C$1.31 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Rakovina Therapeutics Ending Cash Position?

Rakovina Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2024 was C$1.31 Mil.

Rakovina Therapeutics's quarterly Ending Cash Position declined from Jun. 2024 (C$1.39 Mil) to Sep. 2024 (C$0.26 Mil) but then increased from Sep. 2024 (C$0.26 Mil) to Dec. 2024 (C$1.31 Mil).

Rakovina Therapeutics's annual Ending Cash Position declined from Dec. 2022 (C$0.90 Mil) to Dec. 2023 (C$0.44 Mil) but then increased from Dec. 2023 (C$0.44 Mil) to Dec. 2024 (C$1.31 Mil).

Rakovina Therapeutics Ending Cash Position Historical Data

The historical data trend for Rakovina Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rakovina Therapeutics Ending Cash Position Chart

Rakovina Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

2.81

0.90

0.44

1.31

Rakovina Therapeutics Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial											0.44	0.18	1.39	0.26	1.31

Rakovina Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Rakovina Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.436	+	0.877
	=	1.31

Rakovina Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.073	+	-1.76
	=	1.31

Rakovina Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Rakovina Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Rakovina Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (TSXV:RKV) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

RKVTF:USA 7JO:Germany

Address

595 Burrard Street, P.O. Box 49314, Suite 2600, Three Bentall Centre, Vancouver, BC, CAN, V6B 0A5

Website

https://www.rakovinatherapeutics.com

Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some of its products in the pipeline include kt-2000 AI, kt-3000 series. Rakovina gained exclusive use of the Deep Docking AI Platform, enabling it to significantly speed up identifying potential drugs for DNA damage response.

Executives

Jeffrey Bacha	Senior Officer
Alfredo De Lucrezia	Director, Senior Officer
Michael Liggett	Director
Mads Daugaard	Senior Officer
David Hyman	Senior Officer
John Michael Langlands	Senior Officer

Rakovina Therapeutics Headlines

No Headlines